CMS certification 033302
Phoenix Children's Hospital
1919 East Thomas Road, Phoenix, AZ 85016
This page brings together federal quality data for this hospital: its CMS star rating, patient survey results, emergency department times, and death, complication, infection and readmission rates, each compared with the national rate. Everything here comes from CMS and NPPES, the federal sources themselves - not from us.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: Oct 2024 – Sep 2025.
Not reported for this hospital
CMS had too few cases here to publish results for deaths, complications, infections caught in the hospital, readmissions and return visits. That is common at small, rural and specialty hospitals, and says nothing either way about quality.
Clinicians registered at this address
1,266 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 195 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Pediatrics | 276 |
| Hospitalist | 80 |
| Physician Assistant | 69 |
| Pediatric Emergency Medicine | 56 |
| Pediatric Anesthesiology | 50 |
| Pediatric Critical Care Medicine | 46 |
| Clinical | 43 |
| Dietitian, Registered | 42 |
| Neurology with Special Qualifications in Child Neurology | 32 |
| Pediatric Hematology-Oncology | 32 |
| Family | 31 |
| Neonatal-Perinatal Medicine | 26 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $2.7M
- 2020 $1.7M
- 2021 $2M
- 2022 $3.1M
- 2023 $2.1M
- 2024 $2.5M
- 2025 $2.9M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Space rental and facility fees | $26,313 | 15 |
| Grants | $14,500 | 5 |
| Speaking, teaching and other services | $9,000 | 3 |
| Debt forgiveness | $8,897 | 6 |
| Medical devices and supplies on long-term loan | $5,800 | 1 |
| Charitable contributions | $175 | 7 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | $361,025 | 6 |
| E.R. Squibb & Sons, L.L.C. | $296,234 | 4 |
| Ultragenyx Pharmaceutical Inc. | $245,486 | 36 |
| ACADIA Pharmaceuticals Inc | $226,283 | 17 |
| Sumitomo Pharma America, Inc. | $217,500 | 16 |
| Abbvie INC. | $193,973 | 34 |
| Sanofi US Services INC. | $163,516 | 21 |
| Philips North America LLC | $147,941 | 13 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase III Efficacy and Safety Study of Tezepelumab in Patients with Eosinophilic Esoph… AstraZeneca Pharmaceuticals LP | $282,537 |
| A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adolescents (age 12 years to < 18 years) with Symptomatic Obs… E.R. Squibb & Sons, L.L.C. | $275,842 |
| UX143-CL314 Ultragenyx Pharmaceutical Inc. | $243,736 |
| CONGENITAL ATHYMIA PATIENT REGISTRY Sumitomo Pharma America, Inc. · NCT05329935 | $217,500 |
| ACP-101-302 ACADIA Pharmaceuticals Inc · NCT06173531 | $143,314 |
| A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Longterm Safety of Dupilumab in Children 2 to <6 Year… SANOFI US SERVICES INC. · NCT06191315 | $125,516 |
| A Phase 3, Open-Label, Multicenter, Randomized Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Ado… Amgen Inc. | $107,529 |
| MA_PM_Mountain_2022_11496 Philips North America LLC · NCT06372106 | $84,038 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Phoenix Children's Hospital
Does Phoenix Children's Hospital have an emergency room?
No. CMS does not list emergency services at Phoenix Children's Hospital.
Does Phoenix Children's Hospital receive money from drug and device companies?
Drug and device makers reported $2.9M in payments to Phoenix Children's Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.